To mark and celebrate World Aids Day, CapeTalk's Breakfast Show broadcast live from the boardroom of Cipla Medpro, a leading pharmaceuticals company that manufactures world class generic medicines at affordable prices.
Cipla has its origins in India, and Cipla South Africa is 100% owned by Cipla India - a multinational pharmaceutical and biotechnology company that is headquartered in Mumbai.
CapeTalk's Kieno Kammies spoke to Umang Vohra, MD and Global CEO of Cipla about the work the company is doing and their fight against HIV/Aids.
According to Vohra, Cipla has been in existence for the past 84 years and the have managed to operate successfully in countries that most companies find difficult to work in.
Cipla is all about bringing accessibility and affordability closer to patients, making medicine more available to them.— Umang Vohra, MD and Global CEO of Cipla
We also need to make sure that we give great quality medication in the treatment that we give, because medicine is meant to cure and not meant to create more complications.— Umang Vohra, MD and Global CEO of Cipla
Vohra says they work in collaboration with doctors and government to make sure they provide the right medicine for HIV patients.
They work with schools through their corporate social responsibility to educate the youth about HIV/Aids because education and health are fundamental in life, says Vohra.
To hear more about the work Cipla does in providing good quality medication, listen below: